Frontiers in Oncology (Sep 2024)

Corrigendum: TP53 co-mutations in advanced lung adenocarcinoma: comparative bioinformatic analyses suggest ambivalent character on overall survival alongside KRAS, STK11 and KEAP1 mutations

  • Armin Frille,
  • Myriam Boeschen,
  • Hubert Wirtz,
  • Mathias Stiller,
  • Hendrik Bläker,
  • Maximilian von Laffert

DOI
https://doi.org/10.3389/fonc.2024.1473239
Journal volume & issue
Vol. 14

Abstract

Read online

No abstracts available.

Keywords